EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The prevalence of alpha 1 anti trypsin hetero zygotes pi mz in patients with obstructive pulmonary disease


American Review of Respiratory Disease 114(6): 1077-1084
The prevalence of alpha 1 anti trypsin hetero zygotes pi mz in patients with obstructive pulmonary disease
An increased incidence of an intermediate deficiency of serum .alpha.1-antitrypsin resulting from Pi phenotype MZ was reported in patients with chronic obstructive pulmonary disease (COPD). Prevalence of Pi MZ was determined in patients with COPD among 502 subjects referred to a pulmonary function testing laboratory in a region with low concentrations of air pollutants. Control prevalences were obtained from 930 randomly selected subjects in the same community as well as from patients without COPD. Depending on criteria used to define COPD, 155-306 subjects had COPD. Pi MZ prevalence in subjects with COPD varied from 1.5-4 times the prevalence in the community control group and in the patients without COPD. This difference approached significance or was significant. Because Pi MZ was present in only 3.5-4.5% of the patients with COPD, Pi MZ is not a major factor in the etiology of COPD in this community. The higher incidence of Pi MZ in patients with COPD may be explained by a small sample size, bias in selection of study or control population groups, or the development of COPD from interaction between Pi MZ and air pollutants or other factors not present in this community.


Accession: 006740203



Related references

Pulmonary function in hetero zygotes for alpha 1 anti trypsin deficiency a case control study. American Review of Respiratory Disease 120(4): 759-766, 1979

Changes suggesting emphysema in hetero zygotes for alpha anti trypsin deficiency. Clinical Science & Molecular Medicine 52(2): 27P, 1977

Lung function in alpha 1 anti trypsin hetero zygotes pi type mz. American Review Of Respiratory Disease: 708-715, 1974

Interactions of neutrophil elastase serum trypsin inhibitory activity and smoking history as risk factors for chronic obstructive pulmonary disease in patients with mm mz and zz phenotypes for alpha 1 anti trypsin. American Review of Respiratory Disease 116(5): 837-846, 1977

Effect of smoking on lung function in alpha 1 anti trypsin hetero zygotes. Clinical Research 17(3): 553, 1969

The prevalence of alpha 1 anti trypsin a 1 at deficiency in selected groups of patients with chronic obstructive lung disease. Mayo Clinic Proceedings 44(10): 697-710, 1969

Frequency of heterozygous and homozygous alpha anti trypsin deficiencies in patients with pulmonary emphysema abstract homo zygote hetero zygote enz trypsin inhibitory capacity serum assay inst spectrophotometry inherited major cause of disease. Clinical Medicine 17(1): 165, 1969

Mechanism of expiratory air flow limitation in patients with chronic obstructive pulmonary disease associated with alpha 1 anti trypsin deficiency. Am Rev Respir Dis 103(6): 891, 1971

Pathologic patterns of chronic obstructive pulmonary disease in patients with normal and deficient levels of alpha anti trypsin. American Journal of Medicine 54(6): 706-712, 1973

Alpha 1 anti trypsin hetero zygotes pi type mz a longitudinal study of the risk of development of chronic air flow limitation. Chest: 261-264, 1980